Anixa Biosciences (ANIX) Shares Issued (2012 - 2026)
Anixa Biosciences' (ANIX) quarterly Shares Issued came in at $13.0 million in Q2 2026, up 4.24% YoY from $12.5 million in Q2 2025, and up 5.0% on a QoQ basis from $12.4 million in Q4 2025.
Anixa Biosciences (ANIX) Shares Issued (2012 - 2026) Analysis & Trends
Anixa Biosciences (ANIX) has 11 years of Shares Issued data on file, last reported at $13.0 million in Q2 2026.
- Quarterly Shares Issued rose 4.24% year-over-year to $13.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $13.0 million (up 4.24% YoY) and the FY2025 annual result came in at $12.4 million, up 11.1% from the prior year.
- Shares Issued rose to $13.0 million in Q2 2026, from $12.4 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $13.0 million in Q2 2026 to a low of $1111.0 in Q2 2023.
- A 5-year average of $10.1 million and a median of $11.2 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2023 — Shares Issued tumbled 99.99% — and 2024, when it jumped 1012149.68%.
- Tracing ANIX's Shares Issued over 5 years: stood at $8.8 million in 2022, then advanced by 16.15% to $10.2 million in 2023, then gained by 9.08% to $11.2 million in 2024, then increased by 11.1% to $12.4 million in 2025, then increased by 5.0% to $13.0 million in 2026.
- The last three Shares Issued figures came in at $13.0 million (Q2 2026), $12.4 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - | 13.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 13.03 Mn |
| Apr 30, 2026 | 13.03 Mn |
| Oct 31, 2025 | 12.41 Mn |
| Oct 31, 2025 | 12.41 Mn |
| Jul 31, 2025 | 12.48 Mn |
| Jul 31, 2025 | 12.48 Mn |
| Apr 30, 2025 | 12.50 Mn |
| Apr 30, 2025 | 12.50 Mn |
| Jan 31, 2025 | 12.50 Mn |
| Jan 31, 2025 | 12.50 Mn |
| Oct 31, 2024 | 11.17 Mn |
| Oct 31, 2024 | 11.17 Mn |
| Jul 31, 2024 | 11.22 Mn |
| Jul 31, 2024 | 11.22 Mn |
| Apr 30, 2024 | 11.25 Mn |
| Apr 30, 2024 | 11.25 Mn |
| Jan 31, 2024 | 11.32 Mn |
| Jan 31, 2024 | 11.32 Mn |
| Oct 31, 2023 | 10.24 Mn |
| Oct 31, 2023 | 10.24 Mn |